HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide

Mutations in the HNF4A gene cause MODY1 and are associated with an increased risk of Type 2 diabetes mellitus. On the other hand, incretins are hormones that potentiate reductions in blood glucose levels. Given the established role of incretin-based therapy to treat diabetes and metabolic disorders,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Girard, Romain, Darsigny, Mathieu, Jones, Christine, Maloum-Rami, Faïza, Gélinas, Yves, Carpentier, André C., Laplante, Mathieu, Perreault, Nathalie, Boudreau, François
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6414548/
https://ncbi.nlm.nih.gov/pubmed/30862908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-41061-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars